Home › Ocular Hypertension
Pag-aaral pangklinika para sa Ocular Hypertension na nagre-recruit sa U.S.
21 pag-aaral para sa Ocular Hypertension ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
Ayos sa estado
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
iDose TR Administration in an Office-Based Surgery Setting
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07816692REGN22530 for Adults With Primary Open Angle Glaucoma or Ocular Hypertension
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07675824A Study to Evaluate Efficacy and Safety of YSBP Compared to Lumigan in Patients With Glaucoma or Ocular Hypertension
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07661329Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07075718Clarifying the Optimal Application of SLT Therapy Trial
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT04967989Measuring the Effects of Netarsudil, Latanoprost, and Combination Therapy on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT04401982Imaging the Effects of Netarsudil (Rhopressa) on the Trabecular Meshwork in Glaucoma and Ocular Hypertension
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 11, 2026 · NCT07588152Direct vs Standard SLT for Glaucoma: A Noninferiority Trial
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT0740815424-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update May 1, 2026 · NCT07325240DSLT for Reducing Medication in Glaucoma
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Abr 20, 2026 · NCT07390890Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 30, 2026 · NCT07495852Automated Applanation Tonometry - Updated
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 6, 2026 · NCT07298356Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 5, 2026 · NCT07217678Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 27, 2026 · NCT07400926Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone
Nagre-recruitPhase 4
Edad 45 pataas · Lahat ng kasarian · Na-update Ene 21, 2026 · NCT06848946Implementing AI-based Glaucoma Screening Within Federally Qualified Health Centers
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 29, 2025 · NCT06629649Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
Nagre-recruitPhase 3
Edad 22 pataas · Lahat ng kasarian · Na-update Okt 20, 2025 · NCT07218796Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
Nagre-recruitPhase 3
Edad 22 pataas · Lahat ng kasarian · Na-update Okt 20, 2025 · NCT07218783A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2025 · NCT07076303Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2023 · NCT05844384Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 10, 2022 · NCT05401357Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.